SUMMARY Blood nicotine, cotinine, and carboxyhaemoglobin (COHb) concentrations were measured in 392 smokers (255 women and 137 men) of "middle tar" (17-22mg), "low to middle" (11-16mg), and "low tar" (<11mg) cigarettes. Since tar intake cannot yet be measured directly, we devised an index to estimate it based on the use of measured levels of an intake marker (eg, blood nicotine) and the ratio of the tar to marker yields of the cigarettes. This approach was validated by its.ability to enhance the prediction of levels of one marker by use of another. In a practical test, using COHb and the CO/nicotine yield ratio of the cigarettes, the mean blood nicotine concentration of the low tar smokers was predicted to be 31 9ng/ml compared with the measured mean of 31 8ng/ml. Our main findings were that despite substantial compensatory increases in inhalation, the low tar smokers took in about 25% less tar, about 15%/o less nicotine, and about 10% less carbon monoxide than smokers of middle and low to middle tar cigarettes. These results indicate that low tar cigarettes of the type available in Britain since the late 1970s are likely to prove less harmful than other brands. Monitoring of smoke intakes could supplement epidemiological approaches and provide earlier evidence of whether changing cigarette designs lead to any significant dosage reduction that could affect the risk of disease.
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For more than a decade many countries have had policies for reducing the tar and nicotine yields of cigarettes. Such policies are based on the assumption that the amounts taken in by smokers will also be reduced, so lowering their risk of developing smoking related diseases. It has become apparent, however, that much of the potential health benefit is undermined by the tendency of smokers who smoke lower yielding cigarettes to smoke them more intensively. Several studies have shown that despite large reductions in the machine smoked yields of their cigarettes (up to 400,%) smokers who have chosen to smoke a lower yielding brand have blood nicotine,12 cotinine,3 and COHb'4 concentrations similar to or only slightly lower than those of other smokers.
In this paper we compare blood nicotine, cotinine, and COHb levels in smokers of "low tar" (LT) cigarettes (<10.5mg tar per cigarette) with those of "low to middle" and "middle tar" smokers to see the extent to which lower yields are associated with lower intakes. Although tar intake is of particular concern, no direct measures are yet available. We have devised and validated an index of tar intake based on the blood levels of a marker such as nicotine or CO and the tar/nicotine or tar/CO yield ratios of the cigarettes. We use this index to estimate the tar intake of LT smokers compared with smokers of other brands.
Subjects and methods
The study population consisted of cigarette smokers who attended the Maudsley Hospital smokers' clinic during 1978-81. We excluded those who smoked cigars or hand rolled cigarettes and six subjects who smoked cigarettes in the "middle to high" tar category (23-28mg/cig). The number of subjects after these exclusions was 255 women and 137 men.
All subjects attended in the afternoon, having been instructed to smoke their usual brand in their usual way. On arrival they were asked to smoke one of their cigarettes, and a venous blood sample was taken two minutes after they had finished it. Plasma nicotine and cotinine concentrations were measured by gas chromatography5 6 and CO intake was measured using an IL 182 CO-oximeter or an Ecolyzer.7 The tar, nicotine, and CO yields of the cigarettes were Reduction of tar, nicotine and carbon monoxide intake in low tar smokers obtained from the tables published by the Health Departments of the United Kingdom.
An index of tar intake was derived from the measured intake of a marker and the ratio of the tar to marker yields of the cigarette. For example, the index of tar intake using plasma nicotine concentration as a marker was derived as follows: 
VALIDATION OF THE INDEX OF TAR INTAKE
It is not possible at present to validate the index of tar intake against a direct measure. However, if a similar index of intake of one marker (eg, COHb) based on the levels of another marker (eg, blood nicotine) can be shown to enhance the prediction of actual measured levels of the first marker, some validity for the ratio based index of tar intake can reasonably be inferred. In predicting COHb from blood nicotine we found that the index of CO intake (based on the blood nicotine concentration and the CO/nicotine yield ratio) predicted COHb substantially and significantly better than blood nicotine concentration on its own (ie, without taking account of the CO/nicotine yield ratio of the cigarettes). The correlation of the index with COHb was 0-72 compared with 0-60 between blood nicotine alone and COHb. The index therefore accounted for 52uAo of the variation in COHb compared with 360%. in the case of blood nicotine alone. Likewise, in predicting blood nicotine from COHb, the correlation with the index of nicotine intake (based on COHb and the nicotine/CO yield ratio) was 0-69 compared with 0-60 between blood nicotine and COHb alone, a highly significant improvement.
Correlational data of the type described above are concerned with predicting intakes of individual smokers. When comparing large groups or populations, however, much of the variation due to individual differences in intake and differences in half-lives of the markers, etc, will be balanced out. The ability of the index to predict the average levels of smoke components in the LT smokers as a group from the average levels found in the non-LT smokers is illustrated in table 3. The predictions are close to the measured means, suggesting that the estimated reduction in the tar intake of LT smokers, shown in table 2, is also likely to be fairly accurate.
Discussion
Smokers of LT cigarettes had a lower intake of tar, nicotine, and CO than the smokers of higher yielding brands. On average, their estimated intake of tar was about 250uo lower, their intake of nicotine was about 150Ao lower (170uA and 12uA, as measured by blood nicotine and cotinine respectively), and their intake of CO was about 100%, lower.
These differences are substantially less than the reductions in the standard machine smoked yields of their cigarettes (470/A, 390A,, and 34% for tar, nicotine, and CO yields respectively), and this indicates the extent to which the LT smokers were smoking and inhaling more intensively, presumably to compensate for the lower yields. However, it is clear that despite such compensatory changes in smoking behaviour their intake of the three major smoke components was still lower to a statistically and clinically significant degree.
The results were essentially the same in men and women. There were no significant differences between the sexes in the blood levels of any of the intake measures or in the degree of reduction found in LT smokers. Table 3 Comparison of the average levels of smoke components measured in low tar smokers with those predicted from the levels in non low tar smokers using the intake index based on a different intake marker Intake marker used for Predicted Measured Measure predicted prediction level level COHb (9,)
Blood nicotine 7-0 7-1
COHb (94) Blood cotinine 7.3 6-9 Blood nicotine (ng/ml) COHb 31 9 31 8
Blood cotinine (ng/ml) COHb 316 333
Where blood cotinine concentrations were used as the marker or the measure to be predicted the values are based on fewer subjects. The formula used for the prediction of COHb from blood nicotine is shown below. Similar formulae were used to predict the levels of other components using appropriate markers. Predicted COHb in COHb in Blood nicotine x CO/Nicotine yield ratio of LT smokers LT =non LT x smokers smokers Blood nicotine x CO/Nicotine yield ratio of non LT smokers M A H Russell, M J Jarvis, C Feyerabend, and Y Saloojee The reductions in nicotine and CO intake are based on observed levels measured by methods of established reliability. Our findings are consistent with our earlier study' and the more recent report of Ebert et al2 in showing wide individual variation in blood nicotine concentrations with only a small proportion of the variance accounted for by the nicotine yield of the cigarettes. In our present report, however, we have focussed not on how low the correlation is between nicotine yield of cigarettes and blood nicotine concentrations in smokers but rather on the clinical significance of the slope of the regression lines. In other words, we are less concerned here with how much compensation occurs and more concerned with the extent to which it is incomplete. In this respect we disagree with Benowitz et al,3 who conclude that "smokers of low yield cigarettes do not consume less nicotine". Using blood cotinine as their measure of intake, the correlation with yield of cigarette was 0-15, which is similar to our value of 0 13. However, the sample of Benowitz et al was, at 137, too small to detect a 12-17% reduction in nicotine intake as was found in our LT smokers. Our findings also differ slightly from those of Wald et al, who measured COHb levels only and concluded that CO intake was not reduced in smokers of cigarettes with ventilated filters (mainly LT) compared with smokers of cigarettes with unventilated filters (mainly non-LT).4 Their results were based not on the measured COHb levels but on an index which corrected for the previous day's smoking and the reported number of cigarettes smoked on the day and would have relied to some extent on the accuracy of such self-reports.
Our estimate of the reduction in tar intake should be viewed with some caution. The index on which it is based is not a direct measure. Due to lack of reliable evidence we have had to assume that the tar to marker ratios under human smoking conditions are similar to those derived from the standard machine smoked yields or that, if altered, they are altered similarly in LT and non-LT smokers. While it is well known that the yields of all components vary according to the intensity of puffing, it is not clear what happens to the ratios between yields of one component and another. It has been shown that the T/N ratio is reduced by increasing the rate of puffing but increased by taking larger puffs.8 Fortuitously, this might mean that when both puff rate and puff volume are increased the T/N ratio remains fairly constant. The effect on T/N ratios of various attempts to replicate human smoking conditions have so far had conflicting results.12 When more reliable data become available it will be possible to refine our index for estimating tar intake. Meanwhile, the fact that the index, in its present form, has been shown to predict intake better than simple correlation with a marker and the fact that by its use the levels of one marker, predicted from another, were close to the measured levels suggest that our estimate of the reduced tar intake of LT smokers may be fairly accurate.
It is noteworthy that part of the estimated reduction in tar intake reflected the lower ratios of tar to marker yields of LT cigarettes. In other words, tar yields were reduced proportionally more than nicotine and CO yields. Had the reduction in tar yields been proportionally the same, the reduction in tar intake would have been similar to the 10-15% reduction in CO and nicotine intake instead of the 25% reduction estimated. This points to the importance of considering the ratios of the yields of various smoke components to one another as well as their simple reductions.
Two things should be borne in mind when considering our results. Firstly, our sample consisted of heavy smokers whose average daily consumption of 30 cigarettes per day was almost double that of smokers in the general population. It is possible that the results would be different in lighter smokers. Secondly, the LT smokers were self selected in the sense that they themselves had chosen to smoke a LT brand. It is possible that if they smoked a higher yield brand their smoke intake would still be lower than that of non-LT smokers so that their lower intake cannot be attributed to the lower yields of their cigarettes. No Reduction of tar, nicotine and carbon monoxide intake in low tar smokers In conclusion, heavy smokers of present-day LT cigarettes with ventilated filters, despite substantial compensatory increases in inhalation, take in about 250, less tar, about 150%, less nicotine, and about 10%/o less CO than heavy smokers of higher yielding brands. Part of the reduction in tar intake is due to differences in the ratio of the yields as opposed to simple reductions in yields. We cannot say from the present data whether smokers who have not yet switched to a LT brand would show similar reductions if they did.
